SPOTLIGHT -
Treating atrial fibrillation after CABG
FDA Approves Expanded Indication for Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer
The expansion was based on 4-year data from the monarchE study.
Reach Your Business Goals in 2021
In part 1 of our podcast series with American Associated Pharmacies (AAP), AAP President and CEO Jon Copeland dives into key pharmacy industry trends.
FDA Clears First Commercially Available Blood Test to Evaluate for TBI, Concussion
The test is intended to complement the company’s TBI plasma test, which received FDA clearance in 2021.
ThoughtSpot Series: Closing the Healthcare Gap
Our final episode in our ThoughtSpot 2020 podcast series features NPhA president Dr. Ryan Marable and immediate past president Dr. Lakesha Butler, who share insights on health disparities and the social determinants of health.
FDA Accepts Supplemental BLA For Nivolumab For Melanoma
The PDFUA date for the drug is October 13, 2023.
ASHP CEO Urges Biden Administration to Utilize Pharmacists as Care Providers in Opioid Epidemic
The letter outlined 7 steps that the Biden administration can take without the need for additional legislation.
